Eli Lilly said on Thursday it would bring the Mounjaro drug against obesity and diabetes to British patients within weeks after winning clearance for pre-filling it into an.
After a recent myocardial infarction, daily low-dose colchicine reduces the risk for cardiovascular events in patients with type 2 diabetes, a recent study shows.
SGLT2 inhibitors are known to reduce diabetic nephropathy risk in patients with type 2 diabetes, but can they also protect against diabetic retinopathy?
Look AHEAD trial participants who achieved type 2 diabetes remission had lower risks for CKD and CVD, in a dose-response relationship by remission duration.